Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy

23

Sep 2026

Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy

Novai. a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, today announced the publication of a peer-reviewed study in Expert Review of Ophthalmology, which successfully demonstrates its ‘Detection of Apoptosing Retinal Cells’ (DARC) imaging technology as a promising biomarker for identifying patients at high risk of central vision loss caused by macular atrophy (MA).

DePuy Synthes showcases next-generation trauma innovations at OTA 2026

23

Sep 2026

DePuy Synthes showcases next-generation trauma innovations at OTA 2026

DePuy Synthes, a global leader in orthopedic technologies and solutions, will showcase its latest trauma innovations at the 2026 Orthopaedic Trauma Association (OTA) Annual Meeting in Nashville, including four new VOLT™ plating systems, MAXFRAME AUTOSTRUT™ with Bluetooth® Multi-Axial Correction System, VELY™ Trauma AI Assisted Surgery enabling technology, and an expanded value offering for procedural solutions.

Scientists map a giant parasite machine to fight tropical diseases

23

Sep 2026

Scientists map a giant parasite machine to fight tropical diseases

A study conducted between the University of Liège and Rockefeller University reveals, with near-atomic precision, the three-dimensional structure and function of a gigantic molecular machine essential to the survival of trypanosomatid parasites, which cause serious diseases in humans, animals and plants.

Feeling lonely at work? How often you see your colleagues may matter

23

Sep 2026

Feeling lonely at work? How often you see your colleagues may matter

In a nationally representative sample of 7,798 employees in Germany aged 25 to 65, about 26% reported lacking companionship from colleagues, 17% felt excluded, and 8% felt lonely at work at least sometimes. Less frequent direct contact with colleagues was consistently associated with all three facets of workplace loneliness, although the cross-sectional study cannot establish cause and effect.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.